Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?

Raffaele Bruno, Stefano Fagiuoli, Paolo Sacchi

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)699-701
Number of pages3
JournalExpert Review of Anti-Infective Therapy
Issue number9
Publication statusPublished - Sep 2011


  • antiretroviral therapy
  • boceprevir
  • DAA
  • DAA-resistance
  • HIV-HCV coinfection
  • pharmacokinetic interactions
  • telaprevir

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)
  • Microbiology
  • Virology

Cite this